Search Results 131-140 of 16710 for Lou Gehrig's disease

  1. Dennis W. Dickson, M.D. - Mayo Clinic Faculty Profiles

    ... disease and movement disorders. ... Dickson's neuropathological research has included amyotrophic lateral sclerosis, also called Lou Gehrig's disease, and ...

  2. Jubilant First Steps - Mayo Clinic News Network

    ... Lou Gehrig's disease — or cerebral palsy. "She had no muscle control and by ... disorder that mimics the symptoms of Parkinson's disease. "And it's ...

  3. Mayo Clinic President and CEO Participates in the ALS Ice Bucket Challenge, Pledges Support to ALS Research

    Infectious Diseases · Mayo Clinic Minute · Medical ... Mayo Clinic President and CEO Participates in the ALS Ice Bucket Challenge, Pledges Support to ALS Research.

  4. Neurology - Clinical trials

    Search for a disease or condition . Type 3 or ... ALS we aim to eventually identify immune therapies that may provide benefit in ALS. ... syndrome (POTS).

  5. A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS).

  6. Science Saturday: Across time, place to find cures for inherited heart diseases - Mayo Clinic News Network

    ... Lou Gehrig's disease, also known as amyotrophic lateral sclerosis or ALS. He ... disease similar to diseases like ALS. Better yet, they'd identified ...

  7. Leonard Petrucelli, Ph.D. - Mayo Clinic News Network

    mechanisms that cause neurodegeneration in Alzheimer's disease, amyotrophic lateral sclerosis. (ALS), or Lou Gehrig's disease, and frontotemporal dementia (FTD) ...

  8. A Study to Evaluate Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis - Mayo Clinic

    Diseases & Conditions A-Z ... ALS patients every 3 months for a total of 4 injections over 12 months. ... Participant eligibility includes age, gender, type and ...

  9. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR ( ...

  10. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS - Mayo Clinic

    ... ALS. Print details. Share; Facebook · Twitter. Overview ... ALS . MSC-NTF ... History of autoimmune disease, myelodysplastic or myeloproliferative disorder ...